In vitro activity of new quinoxaline compounds against Campylobacter species and Clostridium difficile
- 30 September 1993
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 17 (2) , 177-179
- https://doi.org/10.1016/0732-8893(93)90031-2
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Empiric Treatment of Acute Diarrheal Disease with NorfloxacinAnnals of Internal Medicine, 1992
- High-Level Quinolone Resistance in Clinical Isolates of Campylobacter jejuniThe Journal of Infectious Diseases, 1992
- Fluoroquinolone resistance in Campylobacter spp isolated from human stools and poultry productsThe Lancet, 1990
- In vitro activities of lomefloxacin and temafloxacin against pathogens causing diarrheaAntimicrobial Agents and Chemotherapy, 1989
- Erythromycin-resistant Campylobacter infections in ThailandAntimicrobial Agents and Chemotherapy, 1987
- Comparative in vitro activities of twelve antimicrobial agents against Campylobacter speciesAntimicrobial Agents and Chemotherapy, 1985
- Antibacterial activities of nitrothiazole against Campylobacter jejuni and Campylobacter coliAntimicrobial Agents and Chemotherapy, 1984
- Comparative in vitro activity of ciprofloxacin against Campylobacter spp. and other bacterial enteric pathogensAntimicrobial Agents and Chemotherapy, 1984
- In vitro susceptibilities of 40 Campylobacter fetus subsp. jejuni strains to niridazole and metronidazoleAntimicrobial Agents and Chemotherapy, 1984